Does the media favor AIRS or PIII?

In the previous week, AirSculpt Technologies had 1 more articles in the media than P3 Health Partners. MarketBeat recorded 3 mentions for AirSculpt Technologies and 2 mentions for P3 Health Partners. AirSculpt Technologies' average media sentiment score of 0.31 beat P3 Health Partners' score of 0.22 indicating that AirSculpt Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AirSculpt Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral P3 Health Partners 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend PIII or VMD?

P3 Health Partners currently has a consensus target price of $14.00, indicating a potential upside of 33.61%. Given P3 Health Partners' higher possible upside, equities analysts plainly believe P3 Health Partners is more favorable than Viemed Healthcare. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score P3 Health Partners 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is AUNA or PIII more profitable?

Auna has a net margin of 1.53% compared to P3 Health Partners' net margin of -8.57%. Auna's return on equity of 16.25% beat P3 Health Partners' return on equity. Company Net Margins Return on Equity Return on Assets Auna 1.53% 16.25% 4.03% P3 Health Partners -8.57% -302.33% -19.99%

Does the media refer more to AUNA or PIII?

In the previous week, Auna had 8 more articles in the media than P3 Health Partners. MarketBeat recorded 10 mentions for Auna and 2 mentions for P3 Health Partners. Auna's average media sentiment score of 0.88 beat P3 Health Partners' score of 0.22 indicating that Auna is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Auna 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive P3 Health Partners 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is LFMD or PIII more profitable?

LifeMD has a net margin of 2.37% compared to P3 Health Partners' net margin of -8.57%. LifeMD's return on equity of -150.88% beat P3 Health Partners' return on equity. Company Net Margins Return on Equity Return on Assets LifeMD 2.37% -150.88% -22.59% P3 Health Partners -8.57% -302.33% -19.99%

Does the media prefer LFMD or PIII?

In the previous week, LifeMD had 9 more articles in the media than P3 Health Partners. MarketBeat recorded 11 mentions for LifeMD and 2 mentions for P3 Health Partners. LifeMD's average media sentiment score of 0.40 beat P3 Health Partners' score of 0.22 indicating that LifeMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeMD 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral P3 Health Partners 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

P3 Health Partners (PIII) Competitors

$10.48 +0.43 (+4.26%)

As of 10:53 AM Eastern

Compare

PIII vs. AIRS, VMD, AUNA, SBC, and LFMD

Should you buy P3 Health Partners stock or one of its competitors? MarketBeat compares P3 Health Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with P3 Health Partners include AirSculpt Technologies (AIRS), Viemed Healthcare (VMD), Auna (AUNA), SBC Medical Group (SBC), and LifeMD (LFMD). These companies are all part of the "healthcare" industry.

How does P3 Health Partners compare to AirSculpt Technologies?

AirSculpt Technologies (NASDAQ:AIRS) and P3 Health Partners (NASDAQ:PIII) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

AirSculpt Technologies presently has a consensus price target of $4.50, indicating a potential downside of 21.79%. P3 Health Partners has a consensus price target of $14.00, indicating a potential upside of 33.61%. Given P3 Health Partners' stronger consensus rating and higher probable upside, analysts plainly believe P3 Health Partners is more favorable than AirSculpt Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, AirSculpt Technologies had 1 more articles in the media than P3 Health Partners. MarketBeat recorded 3 mentions for AirSculpt Technologies and 2 mentions for P3 Health Partners. AirSculpt Technologies' average media sentiment score of 0.31 beat P3 Health Partners' score of 0.22 indicating that AirSculpt Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AirSculpt Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
P3 Health Partners	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

AirSculpt Technologies has higher earnings, but lower revenue than P3 Health Partners. AirSculpt Technologies is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AirSculpt Technologies	$151.82M	2.67	-$11.67M	-$0.17	N/A
P3 Health Partners	$1.46B	0.05	-$147.95M	-$38.60	N/A

AirSculpt Technologies has a net margin of -7.39% compared to P3 Health Partners' net margin of -8.57%. AirSculpt Technologies' return on equity of -4.98% beat P3 Health Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-7.39%	-4.98%	-2.36%
P3 Health Partners	-8.57%	-302.33%	-19.99%

91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are owned by institutional investors. 44.6% of AirSculpt Technologies shares are owned by company insiders. Comparatively, 17.8% of P3 Health Partners shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

AirSculpt Technologies has a beta of 2.31, suggesting that its stock price is 131% more volatile than the broader market. Comparatively, P3 Health Partners has a beta of 1.6, suggesting that its stock price is 60% more volatile than the broader market.

Summary

AirSculpt Technologies beats P3 Health Partners on 11 of the 16 factors compared between the two stocks.

How does P3 Health Partners compare to Viemed Healthcare?

P3 Health Partners (NASDAQ:PIII) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

Viemed Healthcare has a net margin of 5.20% compared to P3 Health Partners' net margin of -8.57%. Viemed Healthcare's return on equity of 10.52% beat P3 Health Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-8.57%	-302.33%	-19.99%
Viemed Healthcare	5.20%	10.52%	7.60%

Viemed Healthcare has lower revenue, but higher earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.05	-$147.95M	-$38.60	N/A
Viemed Healthcare	$270.28M	1.41	$14.93M	$0.37	26.78

P3 Health Partners has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.12, indicating that its share price is 12% more volatile than the broader market.

In the previous week, P3 Health Partners had 2 more articles in the media than Viemed Healthcare. MarketBeat recorded 2 mentions for P3 Health Partners and 0 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.89 beat P3 Health Partners' score of 0.22 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
P3 Health Partners	Neutral
Viemed Healthcare	Very Positive

7.8% of P3 Health Partners shares are owned by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are owned by institutional investors. 17.8% of P3 Health Partners shares are owned by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

P3 Health Partners currently has a consensus target price of $14.00, indicating a potential upside of 33.61%. Given P3 Health Partners' higher possible upside, equities analysts plainly believe P3 Health Partners is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Viemed Healthcare beats P3 Health Partners on 10 of the 15 factors compared between the two stocks.

How does P3 Health Partners compare to Auna?

Auna (NYSE:AUNA) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

Auna has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, P3 Health Partners has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

Auna presently has a consensus price target of $6.97, indicating a potential upside of 52.95%. P3 Health Partners has a consensus price target of $14.00, indicating a potential upside of 33.61%. Given Auna's stronger consensus rating and higher possible upside, equities research analysts clearly believe Auna is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Auna had 8 more articles in the media than P3 Health Partners. MarketBeat recorded 10 mentions for Auna and 2 mentions for P3 Health Partners. Auna's average media sentiment score of 0.88 beat P3 Health Partners' score of 0.22 indicating that Auna is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Auna	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
P3 Health Partners	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Auna has higher earnings, but lower revenue than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Auna	$1.23B	0.27	$27.39M	$0.26	17.52
P3 Health Partners	$1.46B	0.05	-$147.95M	-$38.60	N/A

7.8% of P3 Health Partners shares are held by institutional investors. 17.8% of P3 Health Partners shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Auna has a net margin of 1.53% compared to P3 Health Partners' net margin of -8.57%. Auna's return on equity of 16.25% beat P3 Health Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Auna	1.53%	16.25%	4.03%
P3 Health Partners	-8.57%	-302.33%	-19.99%

Summary

Auna beats P3 Health Partners on 12 of the 16 factors compared between the two stocks.

How does P3 Health Partners compare to SBC Medical Group?

P3 Health Partners (NASDAQ:PIII) and SBC Medical Group (NASDAQ:SBC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

P3 Health Partners has a beta of 1.6, suggesting that its share price is 60% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market.

P3 Health Partners currently has a consensus target price of $14.00, suggesting a potential upside of 33.61%. SBC Medical Group has a consensus target price of $8.50, suggesting a potential upside of 172.87%. Given SBC Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe SBC Medical Group is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

7.8% of P3 Health Partners shares are held by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are held by institutional investors. 17.8% of P3 Health Partners shares are held by insiders. Comparatively, 81.7% of SBC Medical Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

SBC Medical Group has lower revenue, but higher earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.05	-$147.95M	-$38.60	N/A
SBC Medical Group	$173.61M	1.84	$50.99M	$0.39	7.99

SBC Medical Group has a net margin of 24.09% compared to P3 Health Partners' net margin of -8.57%. SBC Medical Group's return on equity of 15.90% beat P3 Health Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-8.57%	-302.33%	-19.99%
SBC Medical Group	24.09%	15.90%	11.61%

In the previous week, P3 Health Partners had 2 more articles in the media than SBC Medical Group. MarketBeat recorded 2 mentions for P3 Health Partners and 0 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.87 beat P3 Health Partners' score of 0.22 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company	Overall Sentiment
P3 Health Partners	Neutral
SBC Medical Group	Very Positive

Summary

SBC Medical Group beats P3 Health Partners on 13 of the 16 factors compared between the two stocks.

How does P3 Health Partners compare to LifeMD?

LifeMD (NASDAQ:LFMD) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

35.5% of LifeMD shares are held by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are held by institutional investors. 18.4% of LifeMD shares are held by company insiders. Comparatively, 17.8% of P3 Health Partners shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

LifeMD has a net margin of 2.37% compared to P3 Health Partners' net margin of -8.57%. LifeMD's return on equity of -150.88% beat P3 Health Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	2.37%	-150.88%	-22.59%
P3 Health Partners	-8.57%	-302.33%	-19.99%

LifeMD has a beta of 1.98, meaning that its share price is 98% more volatile than the broader market. Comparatively, P3 Health Partners has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market.

In the previous week, LifeMD had 9 more articles in the media than P3 Health Partners. MarketBeat recorded 11 mentions for LifeMD and 2 mentions for P3 Health Partners. LifeMD's average media sentiment score of 0.40 beat P3 Health Partners' score of 0.22 indicating that LifeMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeMD	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
P3 Health Partners	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeMD has higher earnings, but lower revenue than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$194.05M	1.23	$14.35M	$0.05	98.90
P3 Health Partners	$1.46B	0.05	-$147.95M	-$38.60	N/A

LifeMD currently has a consensus target price of $9.14, suggesting a potential upside of 84.89%. P3 Health Partners has a consensus target price of $14.00, suggesting a potential upside of 33.61%. Given LifeMD's stronger consensus rating and higher possible upside, research analysts plainly believe LifeMD is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

LifeMD beats P3 Health Partners on 14 of the 16 factors compared between the two stocks.

Get P3 Health Partners News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PIII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PIII vs. The Competition

Export

Metric	P3 Health Partners	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$75.62M	$1.59B	$6.42B	$12.34B
Dividend Yield	N/A	N/A	2.69%	5.22%
P/E Ratio	-0.27	78.59	23.80	24.23
Price / Sales	0.05	7.02	527.67	119.15
Price / Cash	N/A	22.87	41.34	57.13
Price / Book	-0.49	4.92	9.99	6.74
Net Income	-$147.95M	-$54.76M	$3.56B	$337.06M
7 Day Performance	-36.38%	0.12%	-1.18%	-0.13%
1 Month Performance	N/A	N/A	N/A	-1.62%
1 Year Performance	61.20%	0.31%	28.52%	33.25%

P3 Health Partners Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PIII P3 Health Partners	2.3158 of 5 stars	$10.48 +4.3%	$14.00 +33.6%	+48.0%	$75.62M	$1.46B	N/A	500
AIRS AirSculpt Technologies	1.6072 of 5 stars	$5.49 +3.0%	$4.50 -18.0%	+11.7%	$376.01M	$151.82M	N/A	240	Gap Down
VMD Viemed Healthcare	3.0285 of 5 stars	$9.62 -0.3%	N/A	+40.8%	$369.95M	$270.28M	26.00	1,382
AUNA Auna	4.7775 of 5 stars	$4.20 -2.6%	$6.97 +65.9%	-32.0%	$319M	$1.23B	16.15	15,254	Insider Trade Gap Up High Trading Volume
SBC SBC Medical Group	4.4307 of 5 stars	$3.12 +1.6%	$8.50 +172.4%	-36.6%	$314.91M	$173.61M	8.00	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PIII) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

P3 Health Partners (PIII) Competitors

PIII vs. AIRS, VMD, AUNA, SBC, and LFMD

How does P3 Health Partners compare to AirSculpt Technologies?

Summary

How does P3 Health Partners compare to Viemed Healthcare?

Summary

How does P3 Health Partners compare to Auna?

Summary

How does P3 Health Partners compare to SBC Medical Group?

Summary

How does P3 Health Partners compare to LifeMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PIII vs. The Competition

P3 Health Partners Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

P3 Health Partners (PIII) Competitors

PIII vs. AIRS, VMD, AUNA, SBC, and LFMD

How does P3 Health Partners compare to AirSculpt Technologies?

Do analysts prefer AIRS or PIII?

Does the media favor AIRS or PIII?

Which has stronger valuation & earnings, AIRS or PIII?

Is AIRS or PIII more profitable?

Do institutionals and insiders have more ownership in AIRS or PIII?

Which has more risk and volatility, AIRS or PIII?

Summary

How does P3 Health Partners compare to Viemed Healthcare?

Is PIII or VMD more profitable?

Which has stronger earnings & valuation, PIII or VMD?

Which has more volatility and risk, PIII or VMD?

Does the media prefer PIII or VMD?

Do institutionals and insiders believe in PIII or VMD?

Do analysts recommend PIII or VMD?

Summary

How does P3 Health Partners compare to Auna?

Which has more risk & volatility, AUNA or PIII?

Do analysts rate AUNA or PIII?

Does the media refer more to AUNA or PIII?

Which has higher valuation & earnings, AUNA or PIII?

Do institutionals & insiders believe in AUNA or PIII?

Is AUNA or PIII more profitable?

Summary

How does P3 Health Partners compare to SBC Medical Group?

Which has more risk and volatility, PIII or SBC?

Do analysts rate PIII or SBC?

Do institutionals & insiders have more ownership in PIII or SBC?

Which has better earnings & valuation, PIII or SBC?

Is PIII or SBC more profitable?

Does the media refer more to PIII or SBC?

Summary

How does P3 Health Partners compare to LifeMD?

Do institutionals and insiders hold more shares of LFMD or PIII?

Is LFMD or PIII more profitable?

Which has more risk & volatility, LFMD or PIII?

Does the media prefer LFMD or PIII?

Which has better valuation & earnings, LFMD or PIII?

Do analysts recommend LFMD or PIII?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PIII vs. The Competition

P3 Health Partners Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools